Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2006

Jun 14, 2006

35134_dirs_2006-06-14_a1a5827d-c780-47ab-82dd-b6055eea6371.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2006-05-15

Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-05-15 Croff Enterprises, Inc Class B Preferred Shares P 5939 $3 Acquired 363545 Direct

Footnotes

F1: This includes 149,130 shares held by Jensen Development Company and 93,354 shares held by C.S.Finance L.L.C., both of which companies are wholly owned by Gerald L. Jensen, the reporting person on this Form 4. The balance of 121,061 shares are owned personally by Gerald L. Jensen.